• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Pain management and Microlactin: Got milk?

April 24, 2017
Robin Downing, DVM, DAAPM, DACVSMR, CVPP, CCRP, CVA, MS

This milk protein concentrate from the milk of hyperimmunized cows, should be your next big moo-ve toward managing pain in feline patients

Photo: Shutterstock.comMilk protein concentrate from the milk of hyperimmunized cows, Microlactin (Duralactin-VPL), is something you should add to your pain management protocol in cats. The hyperimmune milk factor (HIMF) inhibits inflammation in many animal models, effective regardless of the cause of inflammation and demonstrates no evidence of gastrointestinal irritation. It also works by a different mechanism than NSAIDs or corticosteroids.

The first piece of data about the anti-inflammatory active in milk was disclosed in 1981.1

The novel activities illuminated from pharmacologic studies on this molecule include:

> activating macrophages

> inhibiting neutrophil migration

>inhibiting neutrophil adhesion

>inhibiting infection-induced inflammation

>inhibiting arthritis

Advertisement

>suppressing edema (in a rat model)

>inhibiting autoimmune disease.

Microlactin exhibits a very selective mechanism by blocking cytokines that contribute to the perpetuation of inflammation. It modifies the biological response to inflammation and changes the response of cytokines and neutrophils. It alters the signaling to neutrophils that “calls” them to the sites of inflammation. The neutrophils then do not release the destructive enzymes that perpetuate the inflammatory process. There is no NSAID adverse event profile, since much the same efficacy profile as NSAIDs are seen but the action happens by a different mechanism.

Microlactin can be used safely in dogs, cats and horses. The dose in cats (according to experts such as James Gaynor, DVM, MS, DACVA, DAAPM) is 30 to 50 mg/kg orally b.i.d. It takes time for maximal effects. We see initial effects within four to seven days and maximal effects in 10 to 14 days. This is why Microlactin is not well-positioned for acute pain. For chronic pain, during weeks one through three, overlap with an NSAID or a corticosteroid. After week three, continue Microlactin for long-term anti-inflammatory activity.

It's important to be as specific as possible when making your pain management plan. Conduct a medication, feeding and nutraceutical review at each visit. Write everything down, and have clients keep an “activities of daily living (ADL)” journal in order to keep track of exactly what they are doing to manage pain. Once the patient is stable or comfortable, functional and strong, you can consider removing some elements from your pain management procedure.

References

Bordoni A, Danesi F, Dardevet D, et al. Dairy products and inflammation: a review of the clinical evidence. Crit Rev Food Sci Nutr 2015. 

Related Content:

Pain ManagementFeline Medicine
Chronic feline pain from all perspectives
Chronic feline pain from all perspectives
Q&A with a keynote: Elizabeth Colleran, DVM, DABVP (Feline)
Q&A with a keynote: Elizabeth Colleran, DVM, DABVP (Feline)
UC Davis study on eye diseases in kittens
UC Davis study on eye diseases in kittens

Advertisement

Latest News

Viticus group seeks applications for veterinary boot camp scholarship

Unusual parasite strain kills 4 California sea otters

Q&A with a keynote: Jan Bellows, DVM, DAVDC, DABVP, FAVD

Evaluating liver enzyme elevation

View More Latest News
Advertisement